Equities research analysts predict that Perspecta Inc (NASDAQ:PRSP) will report sales of $1.09 billion for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Perspecta’s earnings. The highest sales estimate is $1.10 billion and the lowest is $1.08 billion. Perspecta reported sales of $1.07 billion during the same quarter last year, which would suggest a positive year over year growth rate of 1.9%. The firm is scheduled to announce its next earnings report on Wednesday, August 14th.
According to Zacks, analysts expect that Perspecta will report full-year sales of $4.40 billion for the current year, with estimates ranging from $4.36 billion to $4.43 billion. For the next year, analysts anticipate that the business will report sales of $4.48 billion, with estimates ranging from $4.26 billion to $4.60 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Perspecta.
Perspecta (NASDAQ:PRSP) last issued its earnings results on Wednesday, August 14th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.08 billion. The business’s revenue for the quarter was up 47.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.54 EPS.
PRSP has been the subject of a number of analyst reports. Goldman Sachs Group initiated coverage on shares of Perspecta in a research note on Thursday, May 9th. They set a “sell” rating and a $21.00 target price for the company. Loop Capital boosted their target price on shares of Perspecta to $22.00 and gave the stock a “hold” rating in a research note on Friday, June 7th. Morgan Stanley set a $21.00 target price on shares of Perspecta and gave the stock a “sell” rating in a research note on Monday, June 17th. Zacks Investment Research upgraded shares of Perspecta from a “sell” rating to a “hold” rating in a research note on Tuesday, August 13th. Finally, Cowen downgraded shares of Perspecta from an “outperform” rating to a “market perform” rating and lowered their target price for the stock from $28.00 to $26.00 in a research note on Monday, June 10th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Perspecta presently has a consensus rating of “Hold” and an average price target of $25.17.
Shares of PRSP stock traded up $0.23 on Wednesday, reaching $24.55. 1,006,600 shares of the stock were exchanged, compared to its average volume of 798,305. The business’s 50 day moving average price is $23.31 and its 200 day moving average price is $22.14. Perspecta has a twelve month low of $15.74 and a twelve month high of $26.64.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Wednesday, September 4th will be given a $0.06 dividend. The ex-dividend date of this dividend is Tuesday, September 3rd. This represents a $0.24 dividend on an annualized basis and a yield of 0.98%.
In other Perspecta news, Director Philip O. Nolan bought 4,366 shares of Perspecta stock in a transaction dated Wednesday, July 3rd. The stock was acquired at an average cost of $22.98 per share, with a total value of $100,330.68. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Philip O. Nolan bought 4,257 shares of Perspecta stock in a transaction dated Friday, August 2nd. The stock was acquired at an average cost of $23.37 per share, with a total value of $99,486.09. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 13,328 shares of company stock valued at $300,927.
Large investors have recently made changes to their positions in the company. Vaughan Nelson Investment Management L.P. raised its stake in shares of Perspecta by 10.5% in the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 2,633,910 shares of the company’s stock valued at $53,257,000 after acquiring an additional 250,266 shares during the period. Los Angeles Capital Management & Equity Research Inc. grew its holdings in Perspecta by 76.3% during the 1st quarter. Los Angeles Capital Management & Equity Research Inc. now owns 29,819 shares of the company’s stock worth $603,000 after acquiring an additional 12,910 shares in the last quarter. Advisory Services Network LLC grew its holdings in Perspecta by 4,108.3% during the 1st quarter. Advisory Services Network LLC now owns 16,791 shares of the company’s stock worth $340,000 after acquiring an additional 16,392 shares in the last quarter. Mason Street Advisors LLC grew its holdings in Perspecta by 0.9% during the 1st quarter. Mason Street Advisors LLC now owns 74,785 shares of the company’s stock worth $1,512,000 after acquiring an additional 698 shares in the last quarter. Finally, Raymond James & Associates grew its holdings in Perspecta by 36.6% during the 1st quarter. Raymond James & Associates now owns 223,700 shares of the company’s stock worth $4,523,000 after acquiring an additional 59,888 shares in the last quarter.
Perspecta Company Profile
There is no company description available for Perspecta Inc
Recommended Story: Compound Interest and Why It Matters When Investing
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perspecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perspecta and related companies with MarketBeat.com's FREE daily email newsletter.